Eric Puro: KÄÄPÄ Biotech

<p>Eric Puro is the Founder &amp; CEO of <strong>KÄÄPÄ</strong>&nbsp;Biotech, a Finnish biotechnology company that researches, innovates, and develops novel industry solutions by leveraging the genius of fungi. </p><br><p>Since launching in 2016, <strong>KÄÄPÄ</strong>&nbsp;has established itself as a major player on the mycopreneurial world stage - In addition to securing Chinese and North American distribution agreements and establishing a forest sciences branch, Eric and his team maintain the largest Chaga cultivation network on the planet.</p><br><p>In today's episode, we dive into:</p><br><p> The origin story of <strong>KÄÄPÄ</strong>&nbsp;and why they still hold company meetings in saunas</p><br><p><strong>KÄÄPÄ's</strong> ongoing Series A funding round and what the company will do with their injection of capital</p><br><p>The reclassification of Turkey Tail fungi as a Novel Food in the European Union</p><br><p>Why Mycopreneurs shouldn't be competing against each other</p><br><p>Mushroom traditions of the Sami people in Northern Finland, the only indigenous people living within EU territory</p><br><p>and more</p><br><p>Please rate and review the episode where've you're listening to it </p><br><p><br></p><br><p><br></p><br /><hr><p style='color:grey; font-size:0.75em;'> See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.</p>